USTEKINUMAB

ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe

USTEKINUMAB (14899E)

ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe
14899E
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: First continuing treatment, Whole body

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: First continuing treatment, Face, hand, foot

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: Continuing treatment, Whole body or Continuing treatment, Face, hand, foot - balance of supply
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 1 DPMQ: $794.25 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Steqeyma
Wezlana